Creatio is the leading Academic Center for the Production and Validation of Advanced Therapies of State associated with the University of Barcelona and technological developer with TECNIO accreditation, that promotes innovation and translation.
Creatio perform all the activities and processes following high quality standards under compliance of ISO 9001:2015, GLP (Good Laboratory Practices) and GMP (Good Manufacturing Practices).
With long-standing experience, Creatio provides support and solutions that cover all the development process of a healthcare product to increase the efficiency of the healthcare system and improve the quality of life of society.
With a forceful focus on translation, we use our expertise in cell and molecular biology; in preclinical studies and clinical production; and in regulatory aspects to develop effective cutting-edge drugs and treatments for patients. Our experience in cell, gene therapy and tissue engineering aims to bridge the gap between research and clinical applications.
17 December, 2024
Nowadays, diseases such as cancer, inflammatory diseases, autoimmune diseases and neurodegenerative diseases are a challenge that medicine must face Currently,...
3 October, 2022
Creatio has been the first center to produce lentiviruses for CAR-T (Chimeric Antigen Receptor-T) cells treatment in clinical trials in...
May 3-5, 2025 - 9:00 AM - 4:00 PM
Dr. Canals will present the European project 'Luminate: in situ osteochondral regeneration through bioprinting' in a flash poster talk on...
Place: Riyadh Air Metropolitano, Madrid, Spain
Access the event
